Can Glaucoma Patients Safely Take Celebrex?
Yes, patients with glaucoma can generally take celecoxib (Celebrex) safely, as there is no established contraindication or significant evidence linking celecoxib to worsening glaucoma or elevated intraocular pressure.
Evidence Review
The available evidence does not identify glaucoma as a contraindication to celecoxib use. The FDA drug label for Celebrex 11 lists specific contraindications including hypersensitivity reactions, active GI bleeding, and perioperative CABG surgery pain, but glaucoma is notably absent from this list.
While drug-induced glaucoma is a recognized entity, the literature identifies glucocorticoids as the primary culprit for open-angle glaucoma, and various other drug classes (adrenergic agonists, anticholinergics, SSRIs, antihistamines) for angle-closure glaucoma 2. NSAIDs, including COX-2 inhibitors like celecoxib, are not listed among the medications that cause or exacerbate glaucoma.
Visual Disturbances: A Separate Concern
There are isolated case reports of reversible visual disturbances with celecoxib 34, including temporary blindness, visual field defects, and blurred vision. These reactions:
- Occurred with mean onset of 9.5 days
- Resolved within 3 days of drug discontinuation
- Are estimated at approximately 5 per 10,000 patients 3
- Likely result from interference with retinal blood supply through reduced prostanoid production, not from effects on intraocular pressure
These visual events are distinct from glaucomatous optic neuropathy and do not represent a contraindication for glaucoma patients specifically.
Clinical Considerations When Prescribing Celecoxib
Standard NSAID Precautions Apply
When prescribing celecoxib to any patient, including those with glaucoma, follow established NSAID guidelines 5555:
Cardiovascular Risk Assessment:
- Avoid in patients with recent MI, stroke, or high cardiovascular risk 666
- Use lowest effective dose for shortest duration 7
- Monitor blood pressure (NSAIDs increase BP by average 5 mm Hg) 55
Gastrointestinal Protection:
- Combine with PPI in patients with GI risk factors 57
- Celecoxib may be preferred over non-selective NSAIDs for GI safety 7
Renal Monitoring:
- Avoid in significant renal disease 55
- Monitor renal function in elderly patients 5
- Use caution with concurrent ACE inhibitors or beta-blockers 5
Age Considerations:
Glaucoma-Specific Monitoring
While celecoxib does not affect glaucoma directly, patients with glaucoma warrant attention to:
- Blood pressure control: NSAIDs can elevate BP 55, which may indirectly affect ocular perfusion
- Medication interactions: Ensure no drug-drug interactions with glaucoma medications (beta-blockers, carbonic anhydrase inhibitors)
- Renal function: Many glaucoma patients are elderly with comorbidities requiring careful NSAID dosing 5
Bottom Line
Celecoxib is not contraindicated in glaucoma patients and does not worsen intraocular pressure or glaucomatous optic neuropathy. Prescribe according to standard NSAID guidelines based on cardiovascular, gastrointestinal, and renal risk profiles 557. If visual disturbances occur (rare), discontinue the medication—symptoms resolve within days 3. The decision to use celecoxib should be based on the patient's overall risk profile for NSAID complications, not on the presence of glaucoma itself.